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ABSTRACT
Background Coaches continually seek new ways of
doing things and also refine existing techniques to
improve sporting performance. Coaches are currently
experimenting using ischaemic preconditioning (IPC)
over consecutive days in the hope of improving
competitive performances.
Aims First, to quantify the physiological impact of
1 week of IPC on simulated Keirin cycling performance.
Second, to investigate if biochemical stress markers
are affected over the treatment period.
Methods Using a randomised, sham-controlled
design, 18 active adults undertook seven consecutive
days of IPC treatment (45min occlusion/reperfusion)
applied to each leg at either 220mm Hg (treatment,
n=9) or 20mm Hg (sham, n=9). Urinary measures of
inflammation, oxidative stress and indirect nitric oxide
synthesis were undertaken daily. A simulated Keirin
cycling competition (430 s Wingate tests) was
performed on day 10, with baseline and
postintervention cycling VO2max (days 1, 11 and 18)
and 30 s Wingate tests (day 2) undertaken for
comparison.
Results The treatment group had enhanced mean
cycling power (3.4%), while neopterin and biopterin in
conjunction with total neopterin were significantly
lower (p<0.05) and total biopterin significantly greater
(p<0.05) during the simulated Keirin. Aerobic fitness
measures significantly improved from baseline to
postintervention (VO2peak: 12.8% ", maximal aerobic
power: 18.5% ").
Conclusions Seven consecutive days of IPC
improved aerobic and anaerobic capacity measures,
with modulations in oxidative stress, immune system
activation and nitric oxide/catecholamine synthesis.
BACKGROUND/AIM
Coaches seek new ways to improve sporting
performance, and considerable research has
focused on pre-exercise interventions.1 2
Repetition of using pressure to induce brief
ischaemia (hypoxia) followed by reperfusion
(reoxygenation) is known as ischaemic
preconditioning (IPC). This technique can
increase exercise capacity through altera-
tions in oxygen delivery, blood flow and
fatigue attenuation,3 and results in
improved peak oxygen uptake4 and peak
and mean power during the early stages of
repeated sprint cycling.5 There is currently
insufficient experimental proof to draw
confident conclusions about the potential of
IPC to acutely enhance sports perfor-
mance,6 and this may be explained by
respondents and non-respondents.6 If a
single episode of IPC does enhance perfor-
mance, would repeated exposure over
several days induce an even greater effect?
One recent study repeated IPC over nine
consecutive days but failed to see any
improvement in aerobic capacity.7 Repeated
IPC has been investigated in clinical studies,
with local and remote improvements in
endothelial function, brachial artery flow-
mediated dilation and resting skin microcir-
culation being observed,8–10 although the
physiological basis of this ‘hypercondi-
tioning’ is still to be fully elucidated.11
Oxidative stress is an integral component
of ischaemia/reperfusion,12 while vasodila-
tion improved tissue oxygenation,13 14 and
inflammatory system modulation15 is regu-
lated through single or repetitive ischaemic
treatment. Neopterin, 7,8-dihydroneop-
terin, biopterin, 7,8-dihydrobiopterin and
tetrahydrobiopterin are heterocyclic pterin
compounds metabolised by various cell
types whose detection and elevation repre-
sent perturbations in oxidative stress,
immune system activation and nitric oxide/
catecholamine synthesis.16–21 Collectively,
measurement of these biomarkers should
provide some physiological insight into the
stress response associated with repeated
IPC.
Our research purpose is to assess induced
physiological changes and simulated Keirin
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cycling performance following 7 days of IPC, and seek
to determine if any aerobic capacity changes remain
after an additional 7 days. We also aim to determine if
urinary pterins are affected by the repeated ischaemia-




Eighteen recreationally active (exercising
5.1±1.7 hours/week) sport science students (13 men, 5
women; age: 23.2±7.1 year; height: 177±11.4 cm;
weight: 79.2±12.7 kg; lean body mass: 62.4±11.4 kg;
VO2max: 38.6±5.9mL/min/kg) volunteered for the
study. All procedures performed were in accordance
with the ethical standards of the University of Canter-
bury Human Ethics Committee. Informed consent was
obtained from all individuals.
Experimental design
A randomised, sham-controlled, single-blinded
(researchers only) design was used to assess the impact
of seven consecutive days of IPC sessions on urinary
markers of physiological stress and simulated competi-
tive cycling performance measured through repeated
anaerobic exercise performances. A power analysis for
urinary pterins indicated that we needed nine or more
subjects using a power of 80 and p value <0.05.
Baseline aerobic (VO2max) and anaerobic capacity
(30 s Wingate) tests were performed 48 and 24hours,
respectively, prior to commencing the IPC protocol.
Using relative VO2max, participants were pair-
matched by the lead investigator, and using a coin toss
were randomly allocated into treatment or ‘sham’
group. The participants were told that it was an IPC
study using blood pressure cuffs; however, they were
not told what pressure would be expected to be an
effective treatment. Furthermore, the participants were
unaware as to which treatment group they were in. The
prescribed IPC sessions were performed once a day
over the following 7 days. Participant characteristics are
provided in table 1. Urine samples were collected
(midstream) 5min before each IPC session and stored
on ice after collection and subsequently stored at
 80C until analysis for markers of inflammation,
oxidative stress and indirect nitric oxide/catecholamine
synthesis. After completing all seven IPC treatments,
the participants performed a simulated Keirin (430 s
Wingate tests; 24 hours post) and a second and third
VO2max test (48 hours, 7 days post).
Methodology
All participants visited the laboratory (~20C; humidity
51%) on 12 separate occasions. On the first day, using
a Cyclus 2 ergometer (Leipzig, Germany) and Cortex
Metalyzer 3B (Biophysik, Leipzig, Germany) metabolic
cart, participants performed a progressive VO2max
protocol starting at 100 W with 25W/min increments
until exhaustion. A 30 s Wingate test (external drop
weight equivalent to 10% body weight) performed on a
Monark Ergometer (Ergomedic 894E, Vansbro,
Sweden) was undertaken 24hours later following a
standardised 13min warm-up. Participants received no
verbal encouragement. Fingertip blood lactate capillary
samples (LactatePro, ARKRAY, Kyoto, Japan) were
collected pre, immediately and 5min post Wingate
test. Participants completed an adapted visual analogue
scale (VAS) questionnaire (0–10) of fatigue22 pre, post
and 30min post. A ‘0’ represented ‘no fatigue’ while a
‘10’ represented ‘greatest fatigue possible’. While no
familiarisation testing was performed before the base-
line measurements, the participants were sport science
students and have previously undertaken this type of
testing. Nevertheless, the participants have had limited
experienced with the particular testing, and we
acknowledge that this is a limitation of the current
study.
After baseline data collection, all participants under-
went either 7 days of daily sham or IPC treatments.
Wingate performance was retested 24 hours after the
final IPC session during an anaerobic simulated cycling
event (Keirin). The purpose of the simulated Keirin
event was to understand the effect of repeated IPC on
repetitive anaerobic exercise, which is common to
many sports. The Keirin is a 2000 m motor-paced velo-
drome cycling event where competitors sprint the final
2½ laps (625 m) comprising ~30 s of anaerobic effort.
A typical Keirin competition involves two morning
races an hour apart with two final races 6 and 7hours
later. Using four Wingate tests, we replicated this time
scale and simulated a Keirin competition. Blood lactate
was collected before, immediately post and 5min post
each Wingate, while urine was collected pre, immedi-
ately post and 30min post each Wingate test, as well as
24hours post. Peak power (W), average power (W) and
fatigue index (%) ([(peak power finishing power)/peak
power]100) were calculated for each Wingate while
participants also completed the same VAS question-
naire pre, post and 30min post.





Age (years) 21.3±5.8 26.1±8.8
Height (cm) 177.3±4.4 176.2±3.4
Weight (kg) 76.6±4.4 81.7±4.1
VO2max (mL/min/kg) 38.2±1.9 39.0±2.1
Pre-IPC peak power (W) 988±300 1063±122
Data are presented as mean±SD.
IPC, ischaemic preconditioning; M, men; W, women; VO2max,
relative VO2 max.
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VO2max testing was conducted 48hours and 7days
following the last IPC session. Each participant was
asked to remain in a euhydrated state and adhere to
their normal diet and activities throughout the 2weeks
of testing while also providing a training diary for the
duration of the studies. Throughout the study, partici-
pants performed their normal training activities
(exercising 5.1±1.7 hours/week). Participants were
instructed to refrain from any form of strenuous exer-
cise, caffeine, supplements or alcohol at least 24 hours
prior to testing. For the Keirin simulation, each partici-
pant consumed water ad lib throughout the day while
adhering to their normal diet.
Repeated IPC protocol
Seven days of repeated IPC was selected from previous
clinically based research investigating the same prin-
ciple.8 While in the supine position, a manual
inflatable cuff (East Shore Medical Supply, Flushing
New York, USA) was positioned on the upper leg
where the adductor longus muscle attaches to the
inguinal ligament. The cuff was 20 cm wide with the
circumference length adjustable from 42 to 57 cm.
Participants received four, 5min episodes of IPC
(220mm Hg) or ‘sham’ treatment (20mm Hg) inter-
spersed with 5min of reperfusion per episode, for each
leg.5 Alternating unilateral occlusion was achieved by
alternating the inflatable cuff from left to right leg
(when one leg received reperfusion, the other was
under ischaemia).23 Toe pulse and oxygen saturation
were monitored by a handheld pulse oximeter
(Vacumed, Ventura, California, USA), with pulse
expected to be non-existent during ischaemia and
oxygen saturation dropping below 90%.
Biochemical analysis
Urine sample preparation, analysis, volume correction,
and quantification of neopterin, biopterin (oxidative
stress), total neopterin (neopterin+7,8 dihydroneop-
pterin; immune system activation) and total biopterin
(biopterin+7,8 dihydrobiopterin (BH2)+tetrahydro-
obiopterin (BH4); nitric oxide/catecholamine synthesis)
were conducted as previously described.20 21 Briefly,
samples were thawed on ice and diluted 1:40 in 20mM
ammonium phosphate, pH 2.5. For total biopterin and
neopterin analysis, 100mL of diluted sample was
aliquoted into a separate microcentrifuge tube. Twenty
microlitres of acidic iodide (5.4% I2/10.8% KI in 1 M
HCl) were added to oxidatively convert BH2 and BH4
to biopterin and 7,8-dihydroneopterin to neopterin
before incubation for 15min in the dark at room
temperature. Following incubation, 10mL of 0.6 M
ascorbic acid was added to reduce the tri-iodine and
100mL was transferred to a high-performance liquid
chromatography (HPLC) phial for strong cation
exchange chromatography analysis (Luna 5mm SCX
100 Å , 2504.6mm column (Phenomenex, California,
USA)) on a Shimadzu LC-20A with UV detector and
autosampler, RF-20A florescence detector and online
degasser, with a 20mM ammonium phosphate pH 2.5
mobile phase pumped isocratically at 1mL/min.
Biopterin and neopterin were detected at 353 nm exci-
tation and 438nm emission. The concentration and
identity of biopterin and neopterin were compared
with their corresponding standard (freshly prepared
each day and spaced evenly throughout each analytical
run) and quantified by peak area using the software
Shimadzu Class VP.
Statistical analysis
The effects of repeated IPC on the change in aerobic
and anaerobic capacity and performance, anaerobic
capacity parameters during the simulated Keirin
competition, and urinary analytes were tested in a
linear mixed-effects model fitted with restricted
maximum likelihood, conducted in the lme4 package
in R V.3.1.1. Between-group and within-group changes
were calculated with p values using Satterthwaite’s
method of denominator synthesis, conducted in the
lmerTest package for R and supported with Cohen’s
effect sizes (d) to evaluate the degree of change. Effect
sizes were interpreted using thresholds of 0.2, 0.6, 1.2
and >2.0 for small, moderate, large and very large,
respectively.24 Changes are reported in comparison
with baseline for each dependent variable, with each
analysed as the response variable in a separate model.
All data are presented as mean±SEM, except for the
anaerobic capacity and performance parameter figures
where the between-participant variability has been
removed according to Cousineau.25 Significance was
set at p<0.05.
RESULTS
All 18 participants completed their respective treat-
ment and undertook the follow-up testing; hence, all
results have been analysed.
Anaerobic measures
Comparisons between pre-IPC and the best 30 s
Wingate of the Keirin simulation (figure 1D–F) reveal
peak power increased 11% (p<0.001, d=0.34), average
power 4.3% (p=0.02, d=0.16) and fatigue index 12.1%
(p=0.01, d=0.79) in the IPC group, while no changes
were observed for the sham group for any of these
parameters. Both groups reported a greater perceived
feeling of fatigue 30min following the first Keirin
Wingate test despite no significant changes in lactate
measures for either group between the pre-IPC and
first Keirin Wingate test (see online supplementary
table 3).
Aerobic measures
Maximal aerobic capacity increased 9.5% 48hours post
IPC treatment with a further increase to 12.8% above
baseline after an additional 7 days (p<0.01, d=0.91,
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moderate effect), as illustrated in figure 1A, B. The
IPC treatment also showed a small (p<0.01, d=0.46)
effect on increasing maximal aerobic power, which
peaked 18.5% above baseline 48 hours postintervention
before regressing back slightly to 16.1% 7days later
(figure 1C). No significant differences were found for
maximal heart rate or respiratory exchange ratio
(RER) values in either group during any of the
VO2max tests (see online supplementary table 1).
Biochemical measures during IPC
Repeated IPC treatment resulted in significant changes
and differences between groups in oxidative stress
markers (p<0.05), with large effect sizes (d=1.91;
d=1.82) for the weekly increase in biopterin and
neopterin, respectively (figure 2). Both groups
displayed large (d=1.91 and d=1.31) within-group
reductions (47% and 36%) in total biopterin for the
IPC (p<0.01) and sham (p<0.05) groups, respectively.
Keirin event simulation
Compared with the first Keirin Wingate test, the IPC
group significantly increased their peak power by 8.7%
in tests 3 and 4 (p<0.001, d=0.14), while there were
no significant changes in the ‘sham’ group (figure 3A).
Average power had a significant but trivial increase for
Wingate 3 and 4 (p<0.05, d<0.10) when compared
with Wingate 1 and 2 (3.2% and 3.4%, respectively) for
the IPC group, but no changes were observed for the
‘sham’ group (figure 3B). While the IPC group’s
fatigue index was elevated during tests 3 and 4
(p<0.01, d=0.34), only Wingate test 3 resulted in
significantly greater (p<0.05, d=0.33) levels of fatigue
for the ‘sham’ protocol (figure 3C).
Figure 1 Changes in relative VO2max (A), absolute VO2max (B), maximum aerobic power (C), peak power (D), average power
(E) and fatigue index (F) for the repeated ischaemic preconditioning (IPC) and ‘sham’ groups (sham=40min/day at 20mm Hg,
IPC=40min/day at 220mm Hg). Data are mean+SEM. *,#p<0.05, **,##p<0.01, ***p<0.001; *within group and #between groups.
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Ratings of perceived fatigue showed similar within-
group trends as both groups experienced increased
levels of fatigue (p<0.01) at specific time points. The
‘sham’ group had higher blood lactate concentrations
prior to test 2 (p<0.05, d=0.67), while no other
statistical differences were observed for either
group.
Total neopterin transiently increased following
Wingate 2 for the IPC group (p=0.02–0.04, d=0.39–
0.42), while sham treatment resulted in sustained eleva-
tions above baseline at several time points (p<0.05,
d=0.33–0.37) (figure 3D). This resulted in significant
differences between groups before Wingate 3
commenced (p=0.04, d=0.35). IPC resulted in
moderate total biopterin increases throughout the
Keirin (p<0.05 to <0.001, d=0.66–0.77) (figure 3E),
with no evident change in the ‘sham’ group (p>0.05).
These changes resulted in small to moderate absolute
differences between groups (p<0.05, d=0.46–0.60)
throughout the simulation.
The oxidised compounds neopterin and biopterin
showed markedly different responses. Neopterin
significantly decreased (p<0.01 to <0.001, d=0.51–
0.71) during the second half of the Keirin simulation
for the IPC group compared with baseline (figure
3F), while an immediate and sustained increase was
observed for the ‘sham’ group (p<0.05 to <0.001,
d=0.53–0.61), which returned to baseline concentra-
tions during Wingate 3 and 4 (figure 3F) before
increasing significantly 24 hours later (p<0.01,
d=1.1). Consequently, IPC resulted in significantly
lower changes (p<0.05 to <0.01, d=0.54–0.66)
compared with ‘sham’ throughout the Keirin simula-
tion and 24hours post (p<0.001, d=1.51). Biopterin
significantly increased compared with baseline imme-
diately prior to the second Wingate test (figure 3G).
Concentrations remained elevated throughout with
greater changes observed for the ‘sham’ group
(p<0.01–0.001, d=0.73–0.81) compared with IPC
(p<0.05 to p<0.001, d=0.61–0.83). This resulted in
statistically greater differences between groups
throughout the third Wingate (p<0.05, d=0.34–0.40)
and 24hours post (p<0.05, d=1.28).
CONCLUSIONS
Utilising repeated daily ischaemia and reperfusion to
elicit an improvement in exercise performance has
only recently been investigated8 26 without consid-
ering its use as a ‘conditioning tool’. The results
suggest that seven consecutive days of IPC may
provide ergogenic benefit; however, the optimal
conditioning required to elicit a performance or
physiological adaptation is yet to be investigated and
Figure 2 Concentration of urinary biochemical markers during 7days of ischaemic preconditioning (IPC) for the IPC and
‘sham’ groups, including total neopterin (A), total biopterin (B), neopterin (C) and biopterin (D). *p<0.05, **p<0.01, ***p<0.001.
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remains a topic of interest in cardioprotection.6 The
magnitude of physiological changes seen is substan-
tially greater than reported by de Groot et al4 and
Lalonde and Curnier27 who noted that a single
application of leg ischaemia improves maximal
oxygen consumption by 3%, aerobic power output by
1.6% and had no change in anaerobic capacity. Our
within-treatment group improvement of 12.8% in
maximal oxygen consumption, 18.5% enhancement
in aerobic power, and 11% and 4.3% increase in
Figure 3 Peak power (A), average power (B), fatigue index (C), total neopterin (D), total biopterin (E), neopterin (F) and
biopterin (G) for the repeated ischaemic preconditioning (IPC) and ‘sham’ protocols during the simulated Keirin competition.
Biochemical concentrations were compared with pre-exercise levels. Data are mean±SEM. *p<0.05, **p<0.01, ***p<0.001.
6 Lindsay A, et al. BMJ Open Sport Exerc Med 2017;3:e000229. doi:10.1136/bmjsem-2017-000229
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peak and average anaerobic power, respectively,
looks to justify 7 days of IPC. Yet our data need to
be carefully considered in relation to the recreation
population recruited, their training status and the
psychological factor where participants may have
knowingly ‘held-back’ with the thought of four
upcoming bouts. Significant elevations in peak and
average power for the IPC group during the Keirin
simulation, two critical determining factors in
repeated bout anaerobic sport, identify the potential
of repeated IPC exposure. These changes are in line
with previous IPC research.28
We undertook performance testing, 24 and 48hours
post the last IPC session, as practically this fits with
when athletes are likely to perform their last exercise
sessions during the taper phase leading into a competi-
tion. Further study could be undertaken to ascertain if
the last IPC session was conducted 72hours prior to
testing and if the repeated IPC effect would still be
present.
Biochemical markers
A review of IPC literature identified a general trend
towards aerobic and anaerobic performance improve-
ment but did not elaborate on the physiological or
biochemical response during each of the condi-
tions.29 It is well-established that IPC results in
cellular and genetic adaptations providing protection
against hypoxic stress30 In an exercise-related
context where significant elevations in oxidative
stress accompany various forms of activity, the adap-
tation potentially developed throughout repeated IPC
may have increased the cells’ ability to modulate the
physiological stress response and more efficiently
improve exercise capacity and performance through
oxidative stress-dependent mechanisms.15 The
finding that only neopterin and biopterin biomarkers
were increased over the week while undertaking the
IPC treatment indicates that while oxidative stress
was increased, there was minimal immune system
activation or nitric oxide/catecholamine synthesis. We
speculate either enhanced radical scavenging, a
change in the type of oxidant generated or increased
oxidative stress. Considering both pterins increased
and Zhou et al31 noting oxidative stress is a necessity
for IPC-induced protection, a change in the oxidant:
antioxidant ratio seems like a plausible scenario. The
lack of change in biomarkers of immune system acti-
vation is in further accordance with Tu et al,15 where
repetitive IPC attenuated increases in inflammatory
mediators.
Repeated IPC resulted in lower levels of indirect
markers of oxidative stress during the Keirin simula-
tion. This may explain the ability to maintain a high
peak power and reduce the decrement in average
power over successive sprints. Increased Reactive
Oxygen Species (ROS) such as those produced
during high-intensity exercise32 has been shown to
modulate skeletal muscle force production,33 while
immune system activation is known to detrimentally
affect the same mechanical properties.34 It could be
postulated that the smaller perturbations in inflam-
mation and oxidative stress experienced in the IPC
group had a smaller impact on the contractile prop-
erties of the skeletal muscles, allowing for more
sustainable and repeatable anaerobic performance.
Repeated IPC also resulted in a significant eleva-
tion in urinary total biopterin, suggesting increased
vasodilation and sympathetic activation as previously
noted.14 This may increase oxygen delivery and satu-
ration within the exercising skeletal muscle tissue for
enhancement of contractile function, which was also
observed between successive bouts.35 Horiuchi et al13
confirmed this potential theory through improved
tissue oxygenation during sympathetic activation at
rest and during moderate exercise following IPC.
The likely increase in vasodilation and subsequent
oxygen delivery in conjunction with previously
reported increased blood vessel density in response
to repeated IPC-initiated hypoxic conditions36 may
provide an explanation for the improvement in
aerobic capacity.
With the possibility that acute or singular sessions
of IPC may improve physiological variables and
sporting performance, coaches will likely prescribe
IPC multiple times over a set period, thereby using
IPC as a conditioning tool. Studies have already
begun to investigate the use of IPC over extended
periods from 7 days8 to 8weeks.10 Future studies
should consider investigating multiple IPC sessions
per day and use of IPC over time periods longer
than 7 days, with different dosages of repeated IPC.
The optimal days before competition to implement
repeated IPC to maximise any benefit needs to be
elucidated.
Repeated IPC over seven consecutive days increased
aerobic and anaerobic capacity and anaerobic exercise
performance in recreational individuals. The changes
were associated with modulations in specific
biomarkers of oxidative stress, inflammation and nitric
oxide/neurotransmitter synthesis.
Summary
" substantially improved aerobic and anaerobic
capacity
" improvement in certain anaerobic capacity parame-
ters over four successive anaerobic bouts
" significant elevations in neopterin and biopterin
during repeated ischaemic preconditioning applica-
tion that were attenuated in conjunction with total
neopterin during repeated anaerobic exercise
" substantially elevated concentrations in total
biopterin during repeated anaerobic exercise
Collectively, these findings suggest that ischaemia/
reperfusion associated with alternating unilateral
repeated IPC provides a physiological stimulus
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capable of improving both aerobic capacity and
anaerobic performance while simultaneously affecting
several physiological mechanisms in recreationally
active participants.
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